You searched for "protection"
Evidence-based hospital management of epistaxis
Epistaxis is the most common presentation to acute ENT services in the UK. However, there are currently no nationally accepted guidelines for its management. The British Rhinological Society, ENT UK and INTEGRATE (The National ENT Trainee Research Network) are working...
Can amplification preserve auditory function?
Hearing loss is a noted modifiable risk factor for dementia, and is also associated with depression, decreased quality of life and isolation. Hearing aids are the main intervention for presbycusis and a 2017 Cochrane Review showed that they have a...
Bevacizumab, NF2, hearing and age
Introduction NF2-related schwannomatosis (NF2-SWN) is an autosomal dominant disorder leading to the development of schwannomas, meningiomas and spinal cord ependymomas. Younger age is a negative prognostic factor. Treatment includes observation, surgery, radiotherapy and medical therapy with bevacizumab (VEGF monoclonal antibody)....Training in Facial Plastic Surgery in the UK
Following the Keogh report earlier this year into the quality of cosmetic surgery in the UK, surgical training in cosmetic surgery is high on the agenda. A Cosmetic Surgery Interspecialty Committee at the Royal College of Surgeons is currently discussing...
Do you use the evidence or do you just know to do that?
In this day and age we generally consider healthcare practice to be evidence-based. Unfortunately there are not always the plethora of research articles available that address the dilemmas of day-to-day clinical practice. This piece of work considers what factors influence...The future of treatments for hearing and balance: a 15 and 50-year perspective
Jameel Muzaffar and Manohar Bance paint a picture of what otology will look like 15 and 50 years’ time. Will we still need doctors? Will there still be an ENT news journal? The last 50 years have seen advances including...Breakthrough tinnitus device Lenire available in three new clinics in Spain
Neuromod has announced that clinically proven tinnitus treatment device, Lenire, is now available in Malaga, Seville and Granada through partnership with medical technology distributor, TRUSBIN.
Artificial intelligence and OSA
The future’s bright, the future’s Orange AI… If you Google ‘how much is AI worth?’, the AI overview tells you “The global artificial intelligence (AI) market size is estimated at approximately $244 billion to $391 billion in 2025 and is...
Less pain more gain: impact of prophylactic gabapentin on swallowing outcomes in head and neck cancer patients undergoing radiation treatment
Patients planned for chemoradiation to the head and neck are usually advised to expect some pain and soreness during their treatment and that pain relief will be offered as and when it is required. Uncontrolled pain and mucositis affect oral...
Voice change after total thyroidectomy with intact laryngeal nerves – a common but temporary problem
It has been reported that up to 87% of patients have a degree of voice dysfunction after thyroidectomy, even when the laryngeal nerves are preserved. Postoperative inflammation, laryngeal oedema due to vascular congestion, direct damage to the cricothyroid muscles and...
Omalizumab for CRSwNP: a monoclonal antibody
A prospective study from London, evaluating the response of chronic rhinosinusitis patients with nasal polyposis who were being treated with monoclonal antibody against IgE for severe allergic asthma. Thirteen patients were treated with Omalizumab, according to UK guidelines for their...
